M. Grecea

Safety and Efficacy of Bevacizumab in Cancer Patients with Inflammatory Bowel Disease

D. Planchard, O. Mir, M. Ducreux, 2022, Cancers.

Managing Hyperprogressive Disease in the Era of Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Blockade: A Case Discussion and Review of the Literature.

S. Ammari, S. Champiat, A. Marabelle, 2020, The oncologist.

Potential Biomarkers for the Efficacy of PD-1-PD-L Blockade in Cancer

T. Ciuleanu, O. Sorițău, M. Zdrenghea, 2021, OncoTargets and therapy.

Clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer.

D. Planchard, N. Chaput, F. Barlesi, 2023, European journal of cancer.